1. Home
  2. EYE vs AUPH Comparison

EYE vs AUPH Comparison

Compare EYE & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYE
  • AUPH
  • Stock Information
  • Founded
  • EYE 1990
  • AUPH 1993
  • Country
  • EYE United States
  • AUPH Canada
  • Employees
  • EYE N/A
  • AUPH N/A
  • Industry
  • EYE Ophthalmic Goods
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • EYE Health Care
  • AUPH Health Care
  • Exchange
  • EYE Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • EYE 900.5M
  • AUPH 999.8M
  • IPO Year
  • EYE 2017
  • AUPH 1999
  • Fundamental
  • Price
  • EYE $11.67
  • AUPH $7.75
  • Analyst Decision
  • EYE Hold
  • AUPH Strong Buy
  • Analyst Count
  • EYE 6
  • AUPH 2
  • Target Price
  • EYE $14.00
  • AUPH $11.50
  • AVG Volume (30 Days)
  • EYE 1.9M
  • AUPH 1.3M
  • Earning Date
  • EYE 05-07-2025
  • AUPH 05-01-2025
  • Dividend Yield
  • EYE N/A
  • AUPH N/A
  • EPS Growth
  • EYE N/A
  • AUPH N/A
  • EPS
  • EYE N/A
  • AUPH 0.04
  • Revenue
  • EYE $1,823,320,000.00
  • AUPH $235,133,000.00
  • Revenue This Year
  • EYE $6.62
  • AUPH $11.86
  • Revenue Next Year
  • EYE $2.62
  • AUPH $24.96
  • P/E Ratio
  • EYE N/A
  • AUPH $193.75
  • Revenue Growth
  • EYE 3.81
  • AUPH 33.97
  • 52 Week Low
  • EYE $9.56
  • AUPH $4.71
  • 52 Week High
  • EYE $19.49
  • AUPH $10.67
  • Technical
  • Relative Strength Index (RSI)
  • EYE 46.31
  • AUPH 46.63
  • Support Level
  • EYE $11.29
  • AUPH $7.59
  • Resistance Level
  • EYE $12.00
  • AUPH $7.83
  • Average True Range (ATR)
  • EYE 0.81
  • AUPH 0.35
  • MACD
  • EYE -0.07
  • AUPH -0.02
  • Stochastic Oscillator
  • EYE 45.86
  • AUPH 65.84

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: